Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (221-230 of 378) with videos related to

Pageof 38
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 29, 2019
l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophanColton Hall, Hannah Wolfe, Alyssa Wells, et al.
Anaesthesia and Intensive Care|February 28, 2007
Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDSM Giacomini, E Borotto, L Bosotti, et al.
Journal of Veterinary Pharmacology and Therapeutics|May 18, 2023
Characterization of P-glycoprotein orthologs from human, sheep, pig, dog, and catMina Azimi, Sook Wah Yee, Andrew Riselli, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Journal of Cardiovascular Pharmacology|June 17, 2009
The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channelBrian F McBride, Tao Yang, Kai Liu, et al.
Clinical Pharmacology and Therapeutics|September 10, 2013
Profiling solute carrier transporters in the human blood-brain barrierE G Geier, E C Chen, A Webb, et al.
Metabolites|August 25, 2023
The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the MouseAnita Wen, Ying Zhu, Sook Wah Yee, et al.
Molecular Pharmacology|April 30, 2015
Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metforminEugene C Chen, Xiaomin Liang, Sook Wah Yee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2016
Interaction of 2,4-Diaminopyrimidine-Containing Drugs Including Fedratinib and Trimethoprim with Thiamine TransportersMarilyn M Giacomini, Jia Hao, Xiaomin Liang, et al.
The AAPS Journal|March 2, 2021
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2Osatohanmwen J Enogieru, Megan L Koleske, Bianca Vora, et al.
Pageof 38

Showing results (221-230 of 378) with videos related to

Sort By:
Pageof 38
Bioorganic & Medicinal Chemistry Letters|June 29, 2019
l-Type amino acid transporter 1 activity of 1,2,3-triazolyl analogs of l-histidine and l-tryptophanColton Hall, Hannah Wolfe, Alyssa Wells, et al.
Anaesthesia and Intensive Care|February 28, 2007
Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDSM Giacomini, E Borotto, L Bosotti, et al.
Journal of Veterinary Pharmacology and Therapeutics|May 18, 2023
Characterization of P-glycoprotein orthologs from human, sheep, pig, dog, and catMina Azimi, Sook Wah Yee, Andrew Riselli, et al.
Clinical Pharmacology and Therapeutics|May 27, 2025
Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)Satoshi Asano, Aleksandra Galetin, Yoshiko Tomita, et al.
Journal of Cardiovascular Pharmacology|June 17, 2009
The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channelBrian F McBride, Tao Yang, Kai Liu, et al.
Clinical Pharmacology and Therapeutics|September 10, 2013
Profiling solute carrier transporters in the human blood-brain barrierE G Geier, E C Chen, A Webb, et al.
Metabolites|August 25, 2023
The Impacts of Slc19a3 Deletion and Intestinal SLC19A3 Insertion on Thiamine Distribution and Brain Metabolism in the MouseAnita Wen, Ying Zhu, Sook Wah Yee, et al.
Molecular Pharmacology|April 30, 2015
Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metforminEugene C Chen, Xiaomin Liang, Sook Wah Yee, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 3, 2016
Interaction of 2,4-Diaminopyrimidine-Containing Drugs Including Fedratinib and Trimethoprim with Thiamine TransportersMarilyn M Giacomini, Jia Hao, Xiaomin Liang, et al.
The AAPS Journal|March 2, 2021
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2Osatohanmwen J Enogieru, Megan L Koleske, Bianca Vora, et al.
Pageof 38